×
Hero Background

Healthcare Bioconvergence Companies

ID: MRFR/HC/10078-HCR
128 Pages
Kinjoll Dey
October 2025

"Healthcare bioconvergence" is a term that may not be widely associated with specific companies or a well-defined industry sector. However, the concept of bioconvergence generally refers to the convergence of various disciplines within the life sciences and healthcare sectors.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Healthcare Bioconvergence Market Research Report - Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Healthcare Bioconvergence Market

Healthcare Bioconvergence Key Companies

 


Latest Healthcare Bioconvergence Companies Update:

BiomX (microbiome therapeutics) Received a Therapeutics Development Award of up to $5 million from the Cystic Fibrosis Foundation to develop phage therapies for cystic fibrosis.


Century Therapeutics (cell therapy) Collaborated with Bristol Myers Squibb to commercialize IPSC-derived allogenic cell-based therapies, strengthening their position in personalized medicine.


Abu Dhabi Department of Health and Israel Innovation Authority Partnered to work on critical health innovation projects, including proof-of-concept and clinical trials.


Life Arc (UK medical research firm) Funded $5.74 million for the Gen OMICC COVID-19 project, supporting patient enrollment, sample collection, and bioinformatics analysis.


List of Healthcare Bioconvergence Key companies in the market

  • Ginkgo Bioworks (US)

  • Thermo Fisher Scientific Inc. (US)

  • GE Healthcare (US)

  • Siemens (Germany)

  • BiomX (Israel)

  • Century Therapeutics (US)

  • Singota Solutions (US)

  • Galvani Bioelectronics (UK)

  • Bico Group (US)

  • SetPoint Medical (US)